Skip to main content
Fig. 3 | BMC Pregnancy and Childbirth

Fig. 3

From: Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey

Fig. 3

Perceptions of risk for known teratogenic drugs. Perception of teratogenic risk by GPs (grey) and OB/GYN (white) of drugs with documented teratogenic potential. Boxplot with medians and 50 % interpercentil ranges with whiskers from the 10th to 90th percentiles representing the answers from GPs (grey and OB/GYN (white). The black boxes represent the estimates of “true” malformation risks for each of the drugs. Statistically significant p-values are indicated

Back to article page